Case Study: Expedient IP Development and Commercialisation using Strategic Transactional Management

An early-stage life sciences industry spin-out sought to utilise strategic collaborations, synergistic partnerships, and licensing agreements to fast track their product development and commercial growth.

To support this growth, the company required a robust IP framework and effective transactional legal support that would work hand-in-hand to protect its innovations and develop its IP assets.

Approach

Transactional IP support included:

In-Licensing Agreements: Negotiated the terms on which core IP was in-licensed into the company.

Strategic Collaborations: Structured partnership arrangements with manufacturers to develop manufacturing processes, increase distribution capabilities, and expand access to U.S. markets. Further drafted detailed IP clauses as to ownership and field as well as territory-based rights of use.

Investigator-Initiated Studies: Facilitated, negotiated, and reviewed study agreements with multiple U.S. hospitals, working alongside U.S. counsel to create templates with the intention of data generation.

Research Agreements: Established research contracts that continued the development of diagnostic uses and, in alignment with the company’s long-term commercial interests, sought to develop its targeted therapies offering.

Supply Agreements: Creation of supply agreements with a network of drug manufacturers in Europe to support the supply of materials for ongoing studies.

Global CRO Agreements: Negotiations with Contract Research Organisations to support studies.

Results

Developing standardised templates and providing consistent contractual input ensured that the company retained the rights of use to expertise, technology, access to strategically important IP (including data). This, and the generation of further IP (including know-how) ensured:

Commercial certainty through uniformity in legal terms across company agreements.

The protection of company confidential information and maintenance of IP asset value.

Streamlined contract negotiations by aligning the company’s commercial strategy with its IP strategy.

Effective demonstration of the company’s ownership of IP, compliance in its research activities, and strong operational and legal fundamentals.

Impact

This strategic transactional management:

Enabled the company to pursue complimentary commercial pathways in parallel.

Supported strategic patent filings.

Positioned the company favourably in the due diligence process leading up to its acquisition, showcasing clear ownership and value within its IP portfolio.

Allowed the company to attract and build strong teams and attract expert scientific advisors.

Demonstrated a proven track record to investors, enhancing its appeal and credibility.

Learn more about out transactional IP services